Table 3 Univariate and multivariate predictors of adverse left ventricular remodeling
Variable | Univariate analysis OR [95% CI] | p-value | Multivariate analysis OR [95% CI] | p-value |
|---|---|---|---|---|
Age (yrs) | 0.9 [0.9–1] | 0.2 |  |  |
Gender Male (%) | 1.5 [1.3–31] | 0.06 |  |  |
Diabetes Mellitus (%) | 0.8 [0.9–1.2] | 0.2 |  |  |
Hypertension (%) | 0.9 [0.8–1.1] | 0.3 |  |  |
Coronary artery disease (%) | 2.2 [1.01–4.8] | 0.001 | 2.64 [1.04–6.7] | 0.04 |
CKDa | 1.7 [1.4–4.3] | 0.03 |  |  |
NYHA class (%) | 2 [1.2–3.5] | 0.05 |  |  |
BNP (pg/ml) | 1.0 [1–1.01] | 0.04 |  |  |
Mitral regurgiation (%) | 3 [1.3–6.5] | 0.05 |  |  |
Rest E/e’ | 1.05 [0.9–1.2] | 0.06 |  |  |
Rest ejection fraction (%) | 1.13 [0.7–1.8] | 0.59 |  |  |
Peak ejection fraction (%) | 0.50 [0.3–0.8] | 0.0059 |  |  |
Rest end-diastolic volume index (ml/m2) | 1.0 [0.9–1.2] | 0.97 |  |  |
Peak end-diastolic volume index (ml/m2) | 1.17 [1.04–1.3] | 0.07 |  |  |
Rest end-systolic volume index (ml/m2) | 0.98 [0.8–1.2] | 0.91 |  |  |
Peak end-systolic volume index (ml/m2) | 1.81 [1.2–3.1] | 0.05 |  |  |
Baseline LVMi (g/m2) | 0.99 [0.97–1.01] | 0.81 |  |  |
Baseline patterns of LV geometry | 1.73 [1.3–2.9] | 0.04 |  |  |
Peak cardiac power output-to-mass (Watt/100 g) | 0.04 [0.02–0.19] | 0.01 |  |  |
Peak LV elastance (mmHg/ml/m2) | 8.3 [3.4–25] | < 0.0001 | 12.5 [4.5–33] | < 0.0001 |